(Q40167055)

18 September 2017

1 reference

title

Dihydroxyanthraquinone and related bis(substituted) aminoanthraquinones: a novel class of antitumor agents (English)

1 reference

18 September 2017

Dihydroxyanthraquinone and related Bis(Substituted) aminoanthraquinones: A novel class of antitumor agents (English)

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

7 October 2023

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

7 October 2023

1

Traganos F

1 reference

18 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6361801

7 October 2023

publication date

1 January 1983

1 reference

full work available at URL

18 September 2017

https://api.elsevier.com/content/article/PII:0163725883900049?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

https://api.elsevier.com/content/article/PII:0163725883900049?httpAccept=text/plain

7 October 2023

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Pharmacology & Therapeutics

7 October 2023

published in

1 reference

18 September 2017

22

1 reference

18 September 2017

2

1 reference

18 September 2017

199-214

1 reference

Phase I clinical trial f mitoxantrone: a new anthracenedione anticancer drug

18 September 2017

2

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Nuclear catalyzed antibiotic free radical formation

7 October 2023

4

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

A general mechanism for microsomal activation of quinone anticancer agents to free radicals

7 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Comparison of Antineoplastic Activity of Aminoethylaminoanthraquinones and Anthracycline Antibiotics

7 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

The interaction of aminoalkylaminoanthraquinones with deoxyribonucleic acid

7 October 2023

10

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Evaluation of the binding of some substituted anthraquinones and naphthacenequinones to DNA

7 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

The nature of adriamycin-induced cytotoxicity in Chinese hamster cells as revealed by premature chromosome condensation

7 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Daunorubicin metabolism in acute nonlymphocytic leukemia

7 October 2023

17

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Experimental antitumor activity of aminoanthraquinones

7 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Interactions of a new antitumor agent, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-9,10-anthracenedione, with nucleic acids

7 October 2023

20

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Spontaneous and Induced Sister Chromatid Exchanges as Revealed by the BUdR-Labeling Method

7 October 2023

21

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Enhanced glycosylation induced by adriamycin

7 October 2023

22

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Anthracenedione activation by nadph-cytochrome p-450 reductase; Comparison with anthracyclines

7 October 2023

23

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Lethal effect of adriamycin on the division cycle of HeLa cells

7 October 2023

24

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Effect of dihydroxyanthraquinone and radiation on G2 progression

7 October 2023

25

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Effect of dihydroxyanthraquinone (DHAQ) and radiation on the survival of cultured Chinese hamster ovary cells

7 October 2023

26

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Comparison of the effects of dihydroxyanthraquinone and adriamycin on the survival of cultured Chinese hamster cells

7 October 2023

27

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Combination of dihydroxyanthraquinone and radiation on L1210 murine leukemia

7 October 2023

28

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Effect of dihydroxyanthraquinone (NSC 279836) and thoracic irradiation on long-term survival of rats

7 October 2023

29

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Effect of dihydroxyanthraquinone on the response of a rat solid tumor to radiation therapy

7 October 2023

30

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Structural considerations in the interaction of DNA and acridines

7 October 2023

31

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Inhibition of DNA and RNA metabolism by daunorubicin and adriamycin in L1210 mouse leukemia

7 October 2023

34

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones

7 October 2023

35

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Effects of adriamycin on surface properties of sarcoma 180 ascites cells

7 October 2023

36

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Adriamycin-induced changes in the surface membrane of sarcoma 180 ascites cells

7 October 2023

37

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Sister-chromatid exchange and chromosomal aberrations by DHAQ and related anthraquinone derivatives in Chinese hamster ovary cells

7 October 2023

39

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Stereochemistry of Intercalation: Interaction of Daunomycin with DNA

7 October 2023

40

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Mechanism of DNA-binding of some aminoalkylamino-derivatives of anthraquinone and naphthacenequinone

7 October 2023

41

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Protein-associated DNA breaks in cells treated with adriamycin or ellipticine

7 October 2023

43

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Qualitative and quantitative aspects of intercalator-induced DNA strand breaks

7 October 2023

44

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Clinical kinetics of 1, 4-dihydroxy-5,8-bis [(2-[(2-hydroxyethyl) amino] ethyl] amino ]-9, 10-anthracenedione

7 October 2023

45

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Effect of 1,4-dihydroxy-5,8-bis (2-(2-hydroxyethylamino) ethyl amino)-9,10-anthracenedione(dihydroxyanthraquinone) on the replication of simian virus 40 chromosome

7 October 2023

46

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Kinetic Response of Cultured Chinese Hamster Cells to Treatment With 4′-[(9-Acridinyl-amino] methanesulphon-m-anisidide-HCl2

7 October 2023

47

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

The ratio of RNA to total nucleic acid content as a quantitative measure of unbalanced cell growth

7 October 2023

49

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Action of dihydroxyanthraquinone on cell cycle progression and survival of a variety of cultured mammalian cells

7 October 2023

50

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Adriamycin: a proposal on the specificity of drug action

7 October 2023

51

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

The anticancer agent adriamycin can be actively cytotoxic without entering cells

7 October 2023

52

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Antiproliferative Activity of Doxorubicin and Aminoanthraquinone Derivatives on Chinese Hamster Ovary Cells

7 October 2023

53

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Drugs which affect the Structure and Function of DNA

7 October 2023

56

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Common Receptor-Complement Feature Among Some Antileukemic Compounds

7 October 2023

57

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Antineoplastic agents. Structure-activity relationship study of bis(substituted aminoalkylamino)anthraquinones

7 October 2023

58

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Structural modification study of bis(substituted aminoalkylamino)anthraquinones. An evaluation of the relationship of the [2-[(2-hydroxyethyl)amino]ethyl]amino side chain with antineoplastic activity

7 October 2023

59

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

Interaction of daunomycin and its derivatives with DNA

7 October 2023

61

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90004-9

7 October 2023

Identifiers

1 reference

18 September 2017

1 reference